No Data
GSK's RSV Vaccine Approved for At-Risk Adults 50-59
GSK's RSV Vaccine Receives Additional EU Approval
European stock markets are hovering near six-week highs as investors await the release of NVIDIA's financial report.
European stock market closed at its highest level since mid-July on Wednesday, as investors awaited the heavyweight financial report from Nvidia. The Stoxx Europe 600 Index rose 0.3% in closing. The chemical and insurance sectors outperformed the large cap market, while the mining sector experienced the largest decline. GlaxoSmithKline rose after the Supreme Court of Delaware in the United States decided to review the lower court's ruling on the Zantac litigation, which involves allegations of Zantac, the company's heartburn treatment drug, causing cancer. The European stock market has recovered from its decline since August, as investors bet on the Federal Reserve's readiness to cut interest rates and the economy's ability to avoid a recession. The Stoxx 600 Index is currently
Over the Counter (OTC) Drugs Market Report 2024-2030: Features Strategic Company Profiles of 42 Players Including Bayer, Boehringer Ingelheim, GlaxoSmithKline, J&J, Novartis, Pfizer, Sanofi, Takeda Pharma
Daily short sale tracking: Walgreens Boots Alliance's short volume increased by 6 million, with a short sale ratio of 18%
The Supreme Court of Delaware will review the cancer-causing evidence of glaxosmithkline (GSK.US)'s Zantac.
The Supreme Court of Delaware will review a previous ruling by a lower court that allowed the evidence submitted by the plaintiff to be heard in the upcoming trial.